Target Protein-binding moiety 8 (Synonyms: N-Deshydroxyethyl BMS-354825) |
| Katalog-Nr.GC33350 |
Zielprotein-bindende Einheit 8 (N-Deshydroxyethyl BMS-354825) ist ein Metabolit von Dasatinib, Dasatinib ist ein Multi-Kinase-Inhibitor, der Bcr-Abl, die Src-Familie und Thrombozyten-Wachstumsfaktor-Rezeptorkinasen wirksam hemmt.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 910297-51-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Target Protein-binding moiety 8 is a compound binding to BCR-ABL, and used for inhibiting BCR-ABL activity.
Target Protein-binding moiety 8 (Compound 8) is a compound binding to BCR-ABL, and used for inhibiting BCR-ABL activity.
[1]. Shibata N, et al. Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands. Cancer Sci. 2017 Aug;108(8):1657-1666.
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *